Table 1 Characteristics of the included studies
Study (Published year) | Inclusion interval | Country | Infected/total joints | Male/female | Mean Age (y) (range) | Study design/type | Site of Arthroplasty | Cut-off value | Method of testing | Diagnosis criteria |
|---|---|---|---|---|---|---|---|---|---|---|
Karbysheva et al. 2020 | 2016.03–2018.06 | Germany | 71/224 | 100/124 | 66.4(30–96) | P Cohort | Knee:125 Hip:99 | 1.3 mmol/L | D-lactam Kita | MSIS |
Sharma et al. 2020 | 2000–2018 | USA | 50/107 | 57/50 | 65.9 | P Cohort | Knee:93 Hip:14 | NR | D-lactam Kit | MSIS |
Yermak et al. 2019 | 2016.05–2017.03 | Germany | 44/148 | 81/67 | 69.5(29–93) | P Cohort | Knee:103 Hip:43 Shoulder:2 | 1.3 mmol/L | D-lactam Kit | EBJIS |
Lenski et al. 2015 | 2007.01–2015.12 | Germany | 67/562 | NR | NR | R Cohort | NA | 5.3 mmol/L | NR | MSIS |
Lenski et al. 2014 | NR | Germany | 21/46 | NR | NR | P Cohort | Knee:47 Hip:19 Elbow:2 | 8.3 mmol/L | NR | MSIS |